Abdullah Algaissi

2.9k total citations · 1 hit paper
45 papers, 1.8k citations indexed

About

Abdullah Algaissi is a scholar working on Infectious Diseases, Animal Science and Zoology and Molecular Biology. According to data from OpenAlex, Abdullah Algaissi has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 9 papers in Animal Science and Zoology and 8 papers in Molecular Biology. Recurrent topics in Abdullah Algaissi's work include SARS-CoV-2 and COVID-19 Research (30 papers), COVID-19 Clinical Research Studies (13 papers) and Animal Virus Infections Studies (9 papers). Abdullah Algaissi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (30 papers), COVID-19 Clinical Research Studies (13 papers) and Animal Virus Infections Studies (9 papers). Abdullah Algaissi collaborates with scholars based in Saudi Arabia, United States and China. Abdullah Algaissi's co-authors include Anwar M. Hashem, Anurodh Shankar Agrawal, Chien‐Te K. Tseng, Naif Khalaf Alharbi, Mazen Hassanain, Bi-Hung Peng, Lanying Du, Xinrong Tao, Lu Lu and Tania Garron and has published in prestigious journals such as The Journal of Immunology, Advanced Functional Materials and Clinical Infectious Diseases.

In The Last Decade

Abdullah Algaissi

41 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

2019 374 citations Anurodh Shankar Agrawal, Abdullah Algaissi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abdullah Algaissi Saudi Arabia	17	1.3k	309	221	213	201	45	1.8k
Samuel M. S. Cheng Hong Kong	17	1.9k 1.5×	342 1.1×	106 0.5×	198 0.9×	204 1.0×	50	2.2k
Thushan I. de Silva United Kingdom	23	1.3k 1.0×	359 1.2×	355 1.6×	100 0.5×	497 2.5×	91	2.2k
Miao Xu China	25	2.1k 1.7×	674 2.2×	416 1.9×	270 1.3×	389 1.9×	68	2.9k
Mike Catton Australia	17	1.8k 1.4×	278 0.9×	183 0.8×	119 0.6×	422 2.1×	34	2.5k
Colin Campbell United Kingdom	13	1.7k 1.4×	307 1.0×	112 0.5×	128 0.6×	395 2.0×	44	2.3k
Weidong Yin China	14	1.8k 1.4×	442 1.4×	232 1.0×	200 0.9×	299 1.5×	30	2.4k
Zhiliang Hu China	16	1.7k 1.4×	255 0.8×	166 0.8×	139 0.7×	342 1.7×	69	2.4k
Natalie Groves United Kingdom	13	1.8k 1.4×	410 1.3×	105 0.5×	142 0.7×	219 1.1×	23	2.3k
Sin‐Yee Fung Hong Kong	13	1.4k 1.1×	493 1.6×	378 1.7×	177 0.8×	155 0.8×	21	2.1k

Countries citing papers authored by Abdullah Algaissi

Since Specialization

Citations

This map shows the geographic impact of Abdullah Algaissi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullah Algaissi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullah Algaissi more than expected).

Fields of papers citing papers by Abdullah Algaissi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullah Algaissi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullah Algaissi. The network helps show where Abdullah Algaissi may publish in the future.

Co-authorship network of co-authors of Abdullah Algaissi

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullah Algaissi. A scholar is included among the top collaborators of Abdullah Algaissi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullah Algaissi. Abdullah Algaissi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rehman, Zia Ur, Hassan A. Alhazmi, Mohammed Albratty, et al.. (2025). Structural insights into PKS13 Thioesterase inhibitors targeting Mycobacterium tuberculosis for drug-resistant tuberculosis therapy: Identification, stability assessment, and pharmacophore modeling. Results in Chemistry. 16. 102388–102388. 1 indexed citations

Alharbi, Ahmad M., Waleed H. Mahallawi, Abdullah M. Assiri, et al.. (2025). Serological insights into MERS-CoV dynamics of antibody responses during acute and convalescent phases and their clinical relevance for diagnostics and immunity. Journal of Infection and Public Health. 18(9). 102854–102854.

Algaissi, Abdullah, Manal Mohamed Elhassan Taha, Edrous Alamer, et al.. (2024). Monkeypox Global Research: A Comprehensive Analysis from Emergence to Present (1961-2023) for innovative prevention and control approaches. Journal of Infection and Public Health. 18(1). 102593–102593. 2 indexed citations

Algaissi, Abdullah, et al.. (2024). Trends and gaps in hydroxychloroquine and COVID-19 research (2020–2023): Performance and conceptual mapping. Journal of Infection and Public Health. 18(3). 102623–102623.

Algaissi, Abdullah, et al.. (2024). COVID-19 and malaria co-infection: a systematic review of clinical outcomes in endemic areas. PeerJ. 12. e17160–e17160. 1 indexed citations

Mahallawi, Waleed H., et al.. (2024). Mucosal immunity in upper and lower respiratory tract to MERS-CoV. Frontiers in Immunology. 15. 1358885–1358885. 1 indexed citations

Algaissi, Abdullah, et al.. (2023). Bacterial Contamination of Mobile Phones Used by Healthcare Workers in Critical Care Units: A Cross-Sectional Study from Saudi Arabia. Microorganisms. 11(8). 1986–1986. 5 indexed citations

Algaissi, Abdullah, Jr‐Shiuan Lin, Wei‐Ting Chen, et al.. (2023). Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus. Vaccine. 41(21). 3337–3346. 8 indexed citations

Lohani, Mohtashim, et al.. (2023). Immunoinformatics Strategy to Develop a Novel Universal Multiple Epitope-Based COVID-19 Vaccine. Vaccines. 11(6). 1090–1090. 11 indexed citations

10.

Alhabbab, Rowa Y., Abdullah Algaissi, Ahmad Bakur Mahmoud, et al.. (2022). Middle East Respiratory Syndrome Coronavirus Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals. Clinical Infectious Diseases. 76(3). e308–e318. 9 indexed citations

11.

Alamer, Edrous, Mushtaq Ahmad Mir, Ali Alasmari, et al.. (2022). Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia. International Journal of Environmental Research and Public Health. 19(4). 2424–2424. 38 indexed citations

12.

Alharbi, Rahaf, Rowa Y. Alhabbab, Sawsan S. Alamri, et al.. (2021). Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1. Vaccines. 9(8). 852–852. 12 indexed citations

13.

Alamer, Edrous, et al.. (2021). Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia. Vaccines. 9(11). 1297–1297. 37 indexed citations

14.

Alhazmi, Abdulaziz, et al.. (2021). Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia. Vaccines. 9(6). 674–674. 118 indexed citations

15.

Alhabbab, Rowa Y., Ahdab Alsaieedi, Abdullah Algaissi, et al.. (2021). Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia. Viruses. 13(7). 1413–1413. 13 indexed citations

16.

Alamer, Edrous, et al.. (2021). Knowledge, Attitudes and Perception toward COVID-19 Vaccines among Adults in Jazan Province, Saudi Arabia. Vaccines. 9(11). 1259–1259. 10 indexed citations

17.

Alhazmi, Abdulaziz, Edrous Alamer, Siddig İbrahim Abdelwahab, et al.. (2021). Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia. International Journal of Environmental Research and Public Health. 18(23). 12451–12451. 10 indexed citations

18.

Hashem, Anwar M., Rowa Y. Alhabbab, Abdullah Algaissi, et al.. (2020). Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies. Pathogens. 9(12). 1067–1067. 7 indexed citations

19.

Agrawal, Anurodh Shankar, Tianlei Ying, Xinrong Tao, et al.. (2016). Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection. Scientific Reports. 6(1). 31629–31629. 43 indexed citations

20.

Tao, Xinrong, Tania Garron, Anurodh Shankar Agrawal, et al.. (2015). Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease. Journal of Virology. 90(1). 57–67. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact